tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Cash flow

2,140 Followers

ACADIA Pharmaceuticals Cash Flow

ACAD's free cash flow for Q3 2023 was $-59.01M. For the 2023 fiscal year, ACAD's free cash flow was decreased by $12.79M and operating cash flow was $-58.95M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -92.54M$ -114.03M$ -125.70M$ -136.17M$ -151.13M$ -167.47M
Investing Cash Flow
$ 14.60M$ 73.24M$ -71.10M$ 192.51M$ -165.84M$ -71.49M
Financing Cash Flow
$ 21.31M$ 8.20M$ 18.16M$ 81.00M$ 371.85M$ 306.65M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 602.76M$ 120.62M$ 153.16M$ 331.80M$ 194.47M$ 139.58M
Income Tax Paid Supplemental Data
$ 2.19M$ 2.19M$ 1.04M$ 1.11M$ 1.60M$ 1.26M
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 21.31M$ 8.20M$ 18.16M$ 81.00M$ 371.85M$ 306.65M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -132.59M$ -114.03M$ -126.83M$ -143.75M$ -152.26M$ -169.57M
Domestic Sales
------
Foreign Sales
------
Currency in USD

ACADIA Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis